Preventing Hepatitis B Transmission from Mother to Child in India

Hepatitis B, a viral infection primarily affecting the liver, presents a significant public health challenge in India, particularly concerning mother-to-child transmission (MTCT). The article from India Today accurately addresses the critical question of whether a Hepatitis B positive mother can transmit the virus to her baby, unequivocally stating that transmission is possible but largely preventable with proper medical intervention. This assertion is strongly corroborated by global health organizations and national guidelines, highlighting the importance of awareness and timely action. Worldwide, mother-to-child transmission is identified as a primary mode of Hepatitis B virus (HBV) spread, especially in highly endemic regions like parts of Asia and Africa. The highest risk of transmission occurs during childbirth, when the baby may come into contact with the mother's infected blood and bodily fluids. Without appropriate preventive measures, infants born to HBsAg-positive mothers, particularly those with a high viral load or who are positive for hepatitis B e antigen (HBeAg), face a substantial risk of infection, with transmission rates potentially reaching between 70% and 90%. If infected at birth, approximately 90% of these newborns will develop chronic Hepatitis B, leading to severe long-term health complications such as cirrhosis and liver cancer later in life. This makes early intervention crucial for preventing chronic infection and its devastating consequences. India carries a considerable burden of Hepatitis B, categorized as an intermediate HBV endemic country. Estimates suggest that India harbors approximately 36 to 40 million chronic HBV carriers, accounting for 10% to 15% of the global pool. The disease contributes significantly to chronic liver disease, cirrhosis, and hepatocellular carcinoma in the country. Studies indicate that despite the severity of the problem, public knowledge and awareness about HBV, as well as vaccination rates, remain suboptimal in India. For instance, it is reported that only 3% of Hepatitis B patients in India are aware of their condition, and less than 1% receive antiviral treatment. Furthermore, only about 45% of newborns receive the Hepatitis B vaccine within 24 hours of birth, despite it being a key preventive step. This underscores the urgent need for enhanced public health interventions and awareness campaigns. To combat MTCT, medical experts and national health authorities emphasize a multi-pronged approach. The Ministry of Health and Family Welfare (MoHFW), Government of India, advocates for universal screening of all pregnant women for Hepatitis B surface antigen (HBsAg) at healthcare facilities. This screening is essential for identifying infected mothers and initiating timely preventive measures. If a mother tests positive, her newborn must receive two critical interventions immediately after birth: the first dose of the Hepatitis B vaccine and a dose of Hepatitis B Immune Globulin (HBIG). These should ideally be administered within 12 to 24 hours of birth. This regimen is highly effective, offering up to 95% protection against lifelong Hepatitis B infection for the newborn. Subsequent doses of the Hepatitis B vaccine are required at one and six months of age to complete the primary series and ensure robust, long-lasting immunity. Beyond immediate postnatal interventions, the World Health Organization (WHO) also recommends antiviral prophylaxis with tenofovir for pregnant women testing positive for HBV infection with a high viral load (HBV DNA ≥ 200,000 IU/mL or ≥ 5.3 log10 IU/mL), typically from the 28th week of pregnancy until at least birth. This maternal antiviral therapy further reduces the risk of transmission to the infant. The MoHFW in India assures that testing, vaccines, and HBIG are available free of cost at designated government healthcare facilities, reinforcing the government's commitment to accessible and equitable healthcare. The National Viral Hepatitis Control Program (NVHCP), launched in 2018, is a comprehensive initiative by the Indian government to achieve the WHO strategy of eliminating viral hepatitis as a public health threat by 2030, aiming for a 90% reduction in incidence and 65% reduction in mortality. This program includes components like awareness generation, immunization, ensuring blood safety, promoting safe practices, and providing free diagnosis and treatment. In conclusion, while the threat of mother-to-child Hepatitis B transmission is real and significant, particularly in India, the medical community and public health initiatives provide clear, effective pathways for prevention. The original article's headline is accurate and reflects the crucial information provided by medical professionals regarding risks and prevention. The emphasis on early screening, timely vaccination, and, when necessary, HBIG and maternal antiviral therapy, is key to safeguarding the health of newborns and mitigating the long-term impact of Hepatitis B across the nation. Collaborative efforts among governments, healthcare providers, and communities are vital to improving awareness and achieving the goal of eliminating viral hepatitis as a public health concern.

Frequently Asked Questions

Read Full Story on Quick Digest